7th Annual Chief Medical Officer Summit Announced by The Conference Forum

NEW YORK, Feb. 21, 2019 /PRNewswire-PRWeb/ -- The Conference Forum is pleased to announce the launch of the 7th Annual Chief Medical Officer Summit for the biotech industry on April 4-5, 2019 at the Hilton Boston Back Bay Hotel, Boston, Massachusetts. The CMO Summit is the only emerging biotech event in the country specifically for chief medical officer peer-to-peer learning, benchmarking and support.

"The role of the chief medical officer is absolutely central to the success of developing therapies in the biotech industry," explains Jennifer Moran, producer of the CMO Summit. "Biotech CMOs face a unique set of challenges, often with limited resources. This summit addresses the particular struggles of the role, which can be an isolated one, with all the responsibility for driving clinical development and CRO management, while meeting the needs of investors. We are pleased to see the growth of the event and to meet the need to bring CMOs together in a support network."

Program leadership for 2019 includes Dr Steven Zelenkofske, EVP, CMO, Achillion Pharmaceuticals; Dr Jim Roach, CMO, Pulmatirx; Dr Beth Trehu, CMO, Jounce Therapeutics; Dr Julie Krop, CMO, EVP, Clinical Development and Regulatory Affairs, AMAG Pharmaceuticals; Dr Zain Kassam, EVP, Clinical Development and Translational Medicine, Finch Therapeutics; and Ken Getz, MBA, Director of Sponsored Research Programs, Tufts CSDD.

2019 Keynotes Announced

2019 Keynote, Dr Steve Kanes, CMO, Sage Therapeutics, shares his experience on navigating a new indication through the FDA as a young company.

Dr Bernie Zeiher, CMO and President, Development, Astellas, also keynotes on the large pharma perspective on partnering with biotech. Dr Zeiher offers valuable insights into what it takes to lead a successful partnership and the need for establishing mutual objectives early on to maximize value for both patients and partners.

Returning by popular demand, Ken Getz provides his annual drug development zeitgeist talk.

-Plus-

For the first time, the CMO Summit features therapeutic area-specific breakout sessions, providing the opportunity for attendees to exchange creative solutions, lessons learned and new pathways in their therapeutic areas. These sessions address some of the most novel fields in the biotech industry, including immuno-oncology, microbiome and gene therapy.

The fireside guest for 2019, Dr Jeffrey Chodakewitz, sits down with program co-chair Dr Julie Krop to share his incredible journey as CMO. Dr Chodakewitz discusses his successes and failures, and his experience transitioning from large pharma to small biotech.

Other special guests include Dr Tak Zaks, CMO, Moderna Therapeutics, who shares his experience in preparing for an IPO, his journey through one of the biggest transitions for a CMO in biotech, lessons learned and life post-IPO.

Dr Aoife Brennan, CMO and CEO, Synlogic and Dr Greg Fiore, CEO, Sollis Therapeutics, discuss navigating the development path from CMO to CEO. They share insights on what to expect in the CEO role, the reality of creating opportunities, and how to deal with the potential hurdles when making that transition.

About the Chief Medical Officer Summit

The CMO Summit is grateful to Dr Elizabeth Stoner, Executive Partner at MPM Capital, who seven years ago encouraged The Conference Forum to produce a conference to support the CMO role.
The CMO Summit is dedicated to accomplishing two goals:

1. To bring together CMO and R&D leadership from emerging biotech to address the unique challenges in directing all R&D functions with limited resources, while raising capital and strategizing for appropriate exits.

2. To create a network of CMO and R&D leadership from small to mid-size life science companies to benchmark, share ideas, develop solutions and provide support.

Learn more about the CMO Summit. Register Here

SOURCE The Conference Forum LLC

Related Links

www.theconferenceforum.org